MARKET

ANPCY

ANPCY

CELLBXHEALTH PLC
OTCQX
0.154
-0.055
-26.32%
Closed 11:59 12/04 EST
OPEN
0.110
PREV CLOSE
0.209
HIGH
0.200
LOW
0.110
VOLUME
20.00K
TURNOVER
2.71K
52 WEEK HIGH
2.390
52 WEEK LOW
0.110
MARKET CAP
--
P/E (TTM)
-0.2297
1D
5D
1M
3M
1Y
5Y
1D
CelLBxHealth Showcases CTC Diagnostic Advances at World ADC Conference
Reuters · 11/05 07:00
BRIEF-Angle Appoints Peter Collins As Interim Chief Executive Officer
Reuters · 10/16 06:37
ANGLE plc Appoints Peter Collins as Interim CEO and Klaas de Boer as Senior Board Advisor
Reuters · 10/16 06:00
ANGLE plc to change name to CelLBxHealth plc
Reuters · 10/08 06:00
ANGLE plc Announces Breakthrough Clinical Study Demonstrating Parsortix System's Ability to Detect Circulating Tumor Cells in Glioblastoma Patients
Reuters · 09/29 06:00
Weekly Report: what happened at ANPCY last week (0908-0912)?
Weekly Report · 09/15 11:48
Angle PLC Announces Board Changes
Barchart · 09/11 21:30
ANGLE plc Reports Decline in Revenue and Increased Loss for H1 2025; EPS at (2.87) Pence
Reuters · 09/10 08:42
More
About ANPCY
Cellbxhealth PLC, formerly ANGLE plc, is a global precision circulating tumor cell (CTC) intelligence company specializing in innovative circulating tumor cell solutions for use in research, drug development and clinical oncology. The product portfolio comprises the Parsortix platform with associated consumables and assays. Its Parsortix platform harvests CTCs from blood and enables comprehensive downstream analysis - including whole-cell imaging, proteomic profiling and full genomic workflows - supporting research, drug development and clinical oncology. Its Parsortix PC1 system is the first FDA cleared medical device for the capture and harvest of intact CTCs from metastatic breast cancer (MBC) patient blood for subsequent, user-validated analysis.Its Parsortix PR1 System is a semi-automated platform for epitope-independent CTC isolation, used in research and clinical trials for multiple cancer types.

Webull offers Cellbxhealth PLC (ADR) stock information, including OTCQX: ANPCY real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, ANPCY stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading ANPCY stock methods without spending real money on the virtual paper trading platform.